2-mercaptoethylguanidine has been researched along with Glial Cell Tumors in 1 studies
2-mercaptoethylguanidine: proposed as a radiation protective agent; minor descriptor (75-83); on-line & Index Medicus search GUANIDINES (75-83); RN given refers to parent cpd
| Excerpt | Relevance | Reference |
|---|---|---|
| "High-grade gliomas are one of the most aggressive human tumors with <1% of patients surviving 5 years after surgery." | 1.34 | Postimmunization with IFN-gamma-secreting glioma cells combined with the inducible nitric oxide synthase inhibitor mercaptoethylguanidine prolongs survival of rats with intracerebral tumors. ( Badn, W; Darabi, A; Salford, LG; Siesjö, P; Smith, KE; Visse, E, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badn, W | 1 |
| Visse, E | 1 |
| Darabi, A | 1 |
| Smith, KE | 1 |
| Salford, LG | 1 |
| Siesjö, P | 1 |
1 other study available for 2-mercaptoethylguanidine and Glial Cell Tumors
| Article | Year |
|---|---|
Postimmunization with IFN-gamma-secreting glioma cells combined with the inducible nitric oxide synthase inhibitor mercaptoethylguanidine prolongs survival of rats with intracerebral tumors.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Enzyme In | 2007 |